Teneggi, V., Ng, M., Tan, D. S., Subbiah, V., Weekes, C., Diermayr, V., … Matter, A. (2016). A phase 1, first-in-human dose escalation study of ETC-159 in advanced or metastatic solid tumours. In ANNALS OF ONCOLOGY (Vol. 27). OXFORD UNIV PRESS.

Teneggi, V., M. Ng, D. S. Tan, V. Subbiah, C. Weekes, V. Diermayr, K. Ethirajulu, et al. “A phase 1, first-in-human dose escalation study of ETC-159 in advanced or metastatic solid tumours.” In ANNALS OF ONCOLOGY, Vol. 27. OXFORD UNIV PRESS, 2016.

Teneggi V, Ng M, Tan DS, Subbiah V, Weekes C, Diermayr V, et al. A phase 1, first-in-human dose escalation study of ETC-159 in advanced or metastatic solid tumours. In: ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2016.

Teneggi, V., et al. “A phase 1, first-in-human dose escalation study of ETC-159 in advanced or metastatic solid tumours.” ANNALS OF ONCOLOGY, vol. 27, OXFORD UNIV PRESS, 2016.

Teneggi V, Ng M, Tan DS, Subbiah V, Weekes C, Diermayr V, Ethirajulu K, Yeo P, Chen D, Gan S, Blanchard S, Nellore R, Lee MA, Hill J, Virshup D, Madan B, Matter A. A phase 1, first-in-human dose escalation study of ETC-159 in advanced or metastatic solid tumours. ANNALS OF ONCOLOGY. OXFORD UNIV PRESS; 2016.